Edition:
India

Shilpa Medicare Ltd (SHME.NS)

SHME.NS on National Stock Exchange of India

259.30INR
16 Oct 2019
Change (% chg)

-- (--)
Prev Close
Rs259.30
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
50,086
52-wk High
Rs435.05
52-wk Low
Rs208.10

Latest Key Developments (Source: Significant Developments)

India's Shilpa Medicare Sets Final Dividend Of 1 Rupee Per Share
Monday, 23 Sep 2019 

Sept 23 (Reuters) - Shilpa Medicare Ltd ::SAYS SETS FINAL DIVIDEND OF 1 RUPEE PER SHARE.  Full Article

India's Shilpa Medicare June-Qtr Consol Net Profit Drops
Tuesday, 13 Aug 2019 

Aug 13 (Reuters) - Shilpa Medicare Ltd ::JUNE QUARTER CONSOL NET PROFIT 157.4 MILLION RUPEES VERSUS 336.4 MILLION RUPEES YEAR AGO.JUNE QUARTER REVENUE FROM OPERATIONS 1.61 BILLION RUPEES VERSUS 1.98 BILLION RUPEES YEAR AGO.  Full Article

Shilpa Medicare Gets USFDA Final Approval For Its ANDA, Docetaxel Injection
Friday, 17 May 2019 

May 17 (Reuters) - Shilpa Medicare Ltd ::SAYS RECEIVED U.S FOOD AND DRUG ADMINISTRATION FINAL APPROVAL FOR ITS ANDA, DOCETAXEL INJECTION.  Full Article

Shilpa Medicare Gets U.S. FDA Final Nod For ANDA, Zoledronic Acid Injection
Thursday, 16 May 2019 

May 16 (Reuters) - Shilpa Medicare Ltd ::RECEIVED U.S. FOOD AND DRUG ADMINISTRATION FINAL APPROVAL FOR ITS ANDA, ZOLEDRONIC ACID INJECTION, 4 MG/5 ML.  Full Article

Shilpa Medicare Gets U.S. FDA Tentative Nod For ANDA, Bortezomid For Injection, 3.5Mg/Vial
Tuesday, 9 Apr 2019 

April 9 (Reuters) - Shilpa Medicare Ltd ::GETS U.S. FDA TENTATIVE APPROVAL FOR ITS ANDA, BORTEZOMID FOR INJECTION, 3.5MG/VIAL.  Full Article

India's Shilpa Medicare Sept-Qtr Consol Net Profit Rises
Wednesday, 14 Nov 2018 

Nov 14 (Reuters) - Shilpa Medicare Ltd ::SEPT QUARTER CONSOL NET PROFIT 422.7 MILLION RUPEES VERSUS PROFIT 341.5 MILLION RUPEES YEAR AGO.SEPT QUARTER CONSOL REVENUE FROM OPERATIONS 1.62 BILLION RUPEES VERSUS 2.04 BILLION RUPEES YEAR AGO.  Full Article

India's Shilpa Medicare March Quarter Consol Profit Falls
Monday, 28 May 2018 

May 28 (Reuters) - Shilpa Medicare Ltd ::MARCH QUARTER CONSOL PROFIT 306.4 MILLION RUPEES VERSUS PROFIT 373.3 MILLION RUPEES YEAR AGO.MARCH QUARTER CONSOL REVENUE FROM OPERATIONS 2.34 BILLION RUPEES VERSUS 2.26 BILLION RUPEES YEAR AGO.  Full Article

Shilpa Medicare Gets EU-GMP Certification From AGES For 2 API Manufacturing Plants, Formulation Facility
Monday, 23 Apr 2018 

April 23 (Reuters) - Shilpa Medicare Ltd ::GOT EU-GMP CERTIFICATION FROM AUSTRIAN AGENCY AGES FOR 2 API MANUFACTURING PLANTS IN KARNATAKA,FORMULATION FACILITY IN TELANGANA.AUSTRIAN AGENCY AGES CARRIED OUT AUDIT OF API PLANTS BETWEEN JAN 16-24 AND FORMULATION FACILITY BETWEEN JAN 25-31.  Full Article

India's Shilpa Medicare ‍Declared Interim Dividend Of 0.70 Rupees Per Shr
Thursday, 22 Feb 2018 

Feb 22 (Reuters) - Shilpa Medicare Ltd ::‍DECLARED INTERIM DIVIDEND OF 0.70 RUPEES PER EQUITY SHARE​.  Full Article

India's Shilpa Medicare Dec-Qtr Consol Profit Falls
Tuesday, 13 Feb 2018 

Feb 13 (Reuters) - Shilpa Medicare Ltd ::DEC QUARTER CONSOL PROFIT 163.4 MILLION RUPEES VERSUS PROFIT OF 170.5 MILLION RUPEES YEAR AGO.DEC QUARTER CONSOL REVENUE FROM OPERATIONS 1.86 BILLION RUPEES VERSUS 1.84 BILLION RUPEES YEAR AGO.  Full Article